DxMedical Cloud™
Technology for overwhelmingly high-speed detection from all over the world.
We use our unique algorithm to deliver the latest technology and product information from around the world in real time.
Explore the future of healthcare with carefully selected information.
Explore the future of healthcare with carefully selected information.
Login
How We Help You To Empower Your Business
POINT 1.
Quickly Deliver Technical Information
We deliver what you seek quickly and in a short time from technical information from all over the world
POINT 2.
Briefly to the Point
A wealth of detailed features makes it easy to understand the main points
POINT 3.
Help with Growth Strategies
The report is also packed with analytical information from the perspective of growth and long-term strategies for business use
Catch Up on the Latest Information
from Around the World
from Around the World
In today's world, where the world is networked by advances in information technology and numerous technologies are evolving at an astonishing speed, it is extremely difficult to manually collect and manage the vast amount of information from all over the world.
DxMedical Cloud™ collects and analyzes professional information from around the world and uses proprietary algorithms to quickly and accurately deliver the information you seek and the best information for you.
search
Quick search in Japanese
You can quickly search for information published in various languages around the world in Japanese. Get the information you need from the vast amount of information available worldwide without having to worry about language barriers.
emergency
Recommendations for You
DxMedical Cloud's proprietary algorithms predict the best information based on your interests and preferences and deliver it to you daily. Stay one step ahead of the curve without the hassle of searching, maximizing your daily information gathering.
Fuzzy Search
In addition to word matching, the search by similar and related keywords delivers news that is often missed due to paraphrasing and shaky spelling.
Japanese Localization
By providing titles and summaries of information from around the world in Japanese, it streamlines the process of “finding” the information you want from search results.
Academic Search
For researchers and professionals, you can search and browse more specialized information, such as articles submitted to journals by universities and research institutes.
More features to enhance your team's productivity
Bookmark
Instantly save and manage information that you like or want to look at later because you don't have time, with the bookmark function. You can access the information you need without hassle, saving you a great deal of time and effort.
Note Editor
Simple and intuitive operation allows you to quickly consolidate all information into a notebook and organize information efficiently. It can be used as a powerful tool for effective information sharing.
Information sharing
A wide range of information sharing tools are available, including chat and note sharing functions. We support information sharing with your team in all situations, from casual information sharing to organizing information in teams.
Collaboration
Provides task management functions specifically designed to make information gathering and sharing more efficient. In addition to regular task management functions, this useful tool supports information gathering and sharing, improving the productivity of the entire team.
DigitalMedical Open Innovation
BrainEnergy produce DigitalMedical open
innovation from Tokyo, where you can experience the intersection of cool and passionate design and
technology.
Transform Your Business With Cloud
Looking for the Future of Health Care
OUR TECHNOLOGY HELPS YOUR BUSINESS
Our technology will help your business
Technology
Sensory evaluation methods for food products targeting different age groups
The sensory evaluation of food products is a critical tool for understanding consumer preferences and ensuring market success across diverse age groups. This narrative review examined sensory evaluation methods tailored for children, adults, and the elderly, aiming to provide practical solutions for designing accurate questionnaires and selecting appropriate evaluation techniques. For children, simplified hedonic scales (e.g., 3-point scales) and nonverbal techniques such as emoji-based assessments and facial expression analysis were effective, given their limited verbal and cognitive capacities. Adults benefited from comprehensive methods like the 9-point hedonic scale, descriptive analysis, and emotion profiling, which provide nuanced insights into preferences. For the elderly, sensory evaluation accounted for age-related declines in olfactory and gustatory sensitivity, as well as the impact of medications and cognitive changes. Tailored methods, including rapid profiling techniques like Check-All-That-Apply (CATA) and texture-modified food evaluations, were essential to address their unique needs. This review highlighted the importance of adapting sensory evaluation protocols to each age group's developmental and physiological characteristics, offering practical recommendations for researchers and industry professionals to improve product development and consumer satisfaction.
Established a technology for comprehensively analyzing the responses of approximately 400 types of olfactory receptors Elucidated that distinct patterns exist for each perceived odor quality
Kao Corporation (President: Yoshihiro Hasebe) Sensory Science Laboratory has achieved a world first by successfully expressing nearly all of the approximately 400 types of olfactory receptors found in humans on the surface of cultured cells. This has enabled the establishment of “ScentVista 400TM,” a technology for comprehensively analyzing the responses of olfactory receptors to odors. This technology suggests that human odor perception can potentially be understood through the reaction patterns of olfactory receptors to the odor molecules they detect.
New Separation Membrane Device Streamlines Antibody Drug Purification Jointly Developed by Domestic Manufacturers Reduces Process Steps to About One-Fourth
Toyobo Co., Ltd. and Otsuka Chemical Co., Ltd. have jointly developed a new separation membrane device that significantly streamlines the purification process for antibody drugs. Its key feature is replacing the conventional column chromatography method, reducing the number of process steps by approximately 75%.
This new device was realized by combining Otsuka Chemical's charged polymer technology with Toyobo's long-cultivated microfabrication and membrane manufacturing expertise. It employs a hollow fiber membrane formed using a charged polymer as a secondary raw material, featuring an asymmetric structure with different pore sizes inside and outside. This allows efficient removal of cell debris, aggregated proteins, and charged impurities simply by passing the solution through the membrane, enabling effective recovery of the target antibody. By eliminating multiple steps traditionally required in column chromatography—such as binding, washing, and elution—it significantly simplifies the workflow.
Toyobo has previously developed membranes for artificial kidney dialysis, ascites filtration, and virus removal. The significant value lies in creating new added value by combining this expertise with Otsuka Chemical's polymer technology.
Antibody drugs are targeted therapies that specifically bind to antigens, offering high efficacy with fewer side effects. The market is projected to grow at an annual rate of approximately 15% until 2030, creating high expectations for efficient manufacturing technologies. Mr. Shimazu from the company's Medical Research Institute, who led the development, emphasized, “Pharmaceutical companies are cautious about changing existing processes, but this technology has the potential to significantly impact efficiency.”
Sample provision to pharmaceutical companies and research institutions began in late April 2025, with mass production planned within the same fiscal year. The company also has internal departments handling antibodies, antigens, and related reagents, and plans to collaborate with these units to expedite evaluation. It aims to achieve sales in the tens of billions of yen for pharmaceutical process membrane applications by fiscal 2030.
AI-Driven Precision Enzyme/Targeted Drug Design: A Platform Combining Cell-Free Experiments and Machine Learning
Ridge Biotechnologies (Ridge Bio) has developed its NativeLink and ProTrigger products for antibody-drug conjugates (ADCs) and targeted drug delivery using a platform that combines cell-free experiments with machine learning. This morning, the company completed an oversubscribed $25 million seed funding round. The Palo Alto-based company raised funds from investors led by Sutter Hill Ventures and is advancing the design of linker systems to deliver drugs specifically to cancer tissues through collaborations with ADC-focused biotech firms. Ridge Bio aims to enable a new class of precision medicine by rapidly generating massive datasets and designing enzymes and prodrugs using proprietary ML models.
The Rising Popularity of Custom-Made Perfumes Among Male Consumers in Japan
MY ONLY FRAGRANCE offers a service where consumers can customize scents based on their preferences. In-store, fragrance advisors blend scents tailored to each consumer's taste, enabling over 110,430,000 possible combinations to provide each customer with a signature scent for a lifetime.By early July 2025, visitor numbers had increased significantly compared to previous periods, with solo male visits rising fivefold and solo female visits increasing 2.5 times. The brand states that fragrance has become widely embraced as a means of self-expression and self-care, becoming integrated into daily life as part of a growing cultural trend. Currently, MY ONLY FRAGRANCE operates 11 stores nationwide in Japan, located in tourist destinations, urban areas, and commercial facilities.
Biotech start-up PeelON secures $1 million to scale compostable packaging for fruits and vegetables
PeelON, a biotech start-up specialising in biodegradable, compostable packaging for fresh produce, has raised $1 million in a seed funding round. The round was led by DeepTech-focused VC, growX ventures, with participation from Boston Venture Group, Clean Energy Venture Group, and Climate Angels.
PeelON, which develops plant-based films that extend the shelf life of fruits and vegetables, operates on a B2B model, working with farmers, exporters, and retailers to eliminate single-use plasti
New plans for 'world-class' mental health hospital
Plans have been submitted for a £750m new mental health hospital and medical research campus.
Oxford Health NHS Foundation Trust said Warneford Park, in Headington, Oxford, would "benefit patients" and support advances in "mental health and brain science".
It added the new hospital would have modern inpatient facilities, emphasising "patient wellness and therapeutic spaces that connect with nature".
The original hospital, which opened in 1826, is thought to be the oldest inpatient unit still in use across the NHS.
Alzheimer's: At-Home Brainwave Test Offers Early Warning
Asimple at-home brainwave test can detect signs of memory impairment linked to Alzheimer's disease years before clinical diagnosis is typically possible.
This feat has been demonstrated by researchers from the universities of Bath and Bristol, in the U.K., who trialed the 'Fastball EEG' technology in patients' homes for the first time.
The three-minute "passive test"—which records electrical activity in the brain while participants view a stream of images—can reliably identify memory problems in people with Mild Cognitive Impairment (MCI)—a condition that can lead to Alzheimer's.
"We're missing the first 10 to 20 years of Alzheimer's with current diagnostic tools. Fastball offers a way to change that—detecting memory decline far earlier and more objectively, using a quick and passive test," said study author George Stothart, a cognitive neuroscientist at Bath, in a statement.
Fullpower-AI Secures 10-Year Global Licensing Agreement and Strategic Investment from Tempur Sealy International to Power the Future of Smartbeds
Fullpower-AI®, a leader in AI-powered health and wellness technologies, today announced a transformative partnership with Tempur Sealy International ("Tempur Sealy"), a wholly-owned business of Somnigroup International Inc., anchored by a 10-year global licensing agreement for Fullpower-AI's KOA Sleeptracker-AI Large Action Model (LAM) platform. As part of the agreement, Tempur Sealy will make a $25 million Series C investment in Fullpower-AI, valuing the company at $160 million.
ÄIO secures €1M to develop fermentation-based oils to replace palm and coconut oils
ÄIO, an Estonian biotech company, has secured €1 million in funding. The company develops sustainable, non-animal fats through fermentation. The funds will accelerate research and development. ÄIO aims to replace traditional oils used in cosmetics and chemicals. Its oils are vegan and environmentally friendly.
The company was founded in 2022 as a spin-off from Tallinn University of Technology. It uses biomass and precision fermentation. The process reduces land use by 97% and water use by 90%, compared to palm oil.
ÄIO offers an eco-conscious alternative to palm and coconut oil. Its oils also serve as a safer, bioactive option over petroleum-based mineral oils. The €1 million grant comes from the Estonian government’s Applied Research Programme. It supports a three-year project focused on fermentation-derived lipids. The total project budget is €1.8 million.
Study uncovers a specialized gut-brain pathway for glucose sensing
On July 9, KAIST (President Kwang Hyung Lee) announced that the research was led by Professor Greg S.B. Suh of the Department of Biological Sciences in collaboration with Professor Young-Gyun Park (BarNeuro), Professor Seung-Hee Lee (Department of Biological Sciences), and researchers at Albert Einstein College of Medicine in New York.
The team demonstrated that, in a state of hunger, animals are capable of detecting and preferentially selecting D-glucose in the gut via a specialized gut-brain circuit.
While it has long been known that the gut transmits caloric information to the brain to regulate appetite—primarily through suppressing hunger-related neurons in the hypothalamus—this study is the first to reveal a nutrient-specific neural pathway that allows the brain to detect glucose itself, not just general caloric content.
ViXion, developer of autofocus eyewear, to exhibit at China's largest nursing care and welfare exhibition
ViXion Co., Ltd. (Headquarters: Chuo-ku, Tokyo; President and CEO: Seiichiro Nanbu; hereinafter referred to as “ViXion”), a company developing and selling autofocus eyewear “ViXion01S,” participated in “CHINA AID 2025,” China's largest welfare, care, and rehabilitation equipment exhibition, held in Shanghai, China, from June 11 (Wed) to 13 (Fri), 2025. Additionally, on June 12 (Thursday), during the official seminar “Japan's Experience × China's Speed: Breaking Through in the Senior Products Market through Japan-China Cooperation,” hosted by the Japan External Trade Organization (JETRO) within the same exhibition, Reimi Takeda, Global Business Division APAC Strategy and Business Development Manager responsible for the Chinese market, delivered a presentation on the global challenges of myopia and presbyopia and the company's technical approach to address these issues.
Sanofi accelerates toward its “Factory of the Future” vision
Sanofi is rapidly advancing its “Factory of the Future” vision and supporting its manufacturing and supply chain goals with new digital initiatives.Utilizing technologies such as digital twins, artificial intelligence (AI), and the Internet of Things (IoT), the “Digital Manufacturing & Supply Accelerator” announced in May 2024 is researching areas such as virtual production simulation, real-time monitoring, and predictive decision-making. The program aims to integrate digital agility across the entire manufacturing value chain to deliver medicines to patients more quickly and efficiently.The company's Digital Manufacturing and Supply Accelerator is located in Lyon, France, and is conducting research toward a vision for future manufacturing plants in 2035 and 2040. The Neuville plant is an innovative facility capable of simultaneously manufacturing four types of biopharmaceuticals and vaccines, featuring digitalization and automation. The company is aiming to realize a “lights-out factory” in the future and has cited digital success stories such as AI-based yield analysis and inventory forecasting.